Louisiana State University

LSU Digital Commons
Faculty Publications

Department of Biological Sciences

8-17-2001

L-Cysteine-mediated Destabilization of Dinitrosyl Iron Complexes
in Proteins
Paul A. Rogers
Huangen Ding
Louisiana State University

Follow this and additional works at: https://digitalcommons.lsu.edu/biosci_pubs

Recommended Citation
Rogers, P., & Ding, H. (2001). L-Cysteine-mediated Destabilization of Dinitrosyl Iron Complexes in Proteins.
Journal of Biological Chemistry, 276 (33), 30980-30986. https://doi.org/10.1074/jbc.M101037200

This Article is brought to you for free and open access by the Department of Biological Sciences at LSU Digital
Commons. It has been accepted for inclusion in Faculty Publications by an authorized administrator of LSU Digital
Commons. For more information, please contact ir@lsu.edu.

THE JOURNAL OF BIOLOGICAL CHEMISTRY
© 2001 by The American Society for Biochemistry and Molecular Biology, Inc.

L-Cysteine-mediated

Vol. 276, No. 33, Issue of August 17, pp. 30980 –30986, 2001
Printed in U.S.A.

Destabilization of Dinitrosyl Iron Complexes

in Proteins*
Received for publication, February 2, 2001, and in revised form, June 15, 2001
Published, JBC Papers in Press, June 21, 2001, DOI 10.1074/jbc.M101037200

Paul A. Rogers and Huangen Ding‡
From the Department of Biological Sciences, Louisiana State University, Baton Rouge, Louisiana 70803

Nitric oxide is a signaling molecule in intercellular
communication as well as a powerful weapon used by
macrophages to kill tumor cells and pathogenic bacteria. Here, we show that when Escherichia coli cells are
exposed to nitric oxide, its ferredoxin [2Fe-2S] cluster is
nitrosylated, forming the dinitrosyl iron complex with a
characteristic EPR signal at gav ⴝ 2.04. Such formed
ferredoxin dinitrosyl iron complex is efficiently repaired in E. coli cells even in the absence of new protein
synthesis. However, the repair activity is completely inactivated once E. coli cells are disrupted, indicating that
repairing the ferredoxin dinitrosyl iron complex requires cellular reducing equivalents. In search of such
cellular factors, we find that L-cysteine can effectively
eliminate the EPR signal of the ferredoxin dinitrosyl
iron complex and release the ferrous iron from the complex. In contrast, N-acetyl-L-cysteine and reduced glutathione are much less effective. L-Cysteine seems to have
a general function, since it can also remove the otherwise stable dinitrosyl iron complexes from proteins in
the cell extracts prepared from the E. coli cells treated
with nitric oxide. We propose that L-cysteine is responsible for removing the dinitrosyl iron complexes from
the nitric oxide-modified proteins into which a new
iron-sulfur cluster will be reassembled.

Nitric oxide has multiple physiological functions. At low concentrations, nitric oxide acts as a signaling molecule for intercellular communications (1). At high concentrations, nitric oxide can be a powerful toxic agent that kills pathogenic bacteria
and tumor cells (2). Among cellular components, proteins that
contain iron-sulfur clusters are considered one of nitric oxide’s
targets (3– 8). In the last decade, iron-sulfur proteins have been
found in many important biological processes including energy
metabolism (6, 9), cellular iron homeostasis (10), heme biosynthesis (11), DNA repair (12–14), DNA synthesis (15), and transcription regulation (16, 17). When purified iron-sulfur proteins are treated with nitric oxide, the iron-sulfur clusters are
converted to the stable dinitrosyl iron complex, which has a
characteristic EPR signal at gav ⫽ 2.04 (6, 11, 18 –21). The
same EPR signal at gav ⫽ 2.04 has also been observed in
microorganisms and animal tissues when treated with nitric
oxide (3, 22, 23) and in activated macrophages where nitric
oxide was physiologically produced by inducible nitric oxide

synthase (5, 24). The implication of these observations is that
cellular iron-sulfur proteins may be modified, forming the dinitrosyl iron complexes, when cells are exposed to nitric oxide
(19). However, the origin of the EPR signals at gav ⫽ 2.04 in
living organisms has been a controversy. Vanin et al. suggested
that the EPR signal at gav ⫽ 2.04 observed in cells could reflect
the dinitrosyl iron complexes formed with small molecular
thiols and cellular “free” iron (25). The argument was based on
the fact that the EPR signal at gav ⫽ 2.04 can be reproduced
with small molecular thiols and the ferrous iron mixed with
nitric oxide in vitro (26). Here, we use the Escherichia coli
ferredoxin [2Fe-2S] cluster as an example and demonstrate
that the ferredoxin protein purified from E. coli cells treated
with nitric oxide has been modified, forming the stable ferredoxin dinitrosyl iron complex. Significantly, our results also
show that such modified ferredoxin dinitrosyl iron complex is
rapidly repaired in the E. coli cells even in the presence of the
protein synthesis inhibitor chloramphenicol.
Modification of the iron-sulfur cluster in proteins by nitric
oxide will inevitably change the protein activities (6, 11, 18,
21). If the cells are to survive, the modified iron-sulfur proteins
will have to be efficiently repaired. At present, little is known
about the cellular repair mechanism for the modified ironsulfur clusters in proteins by nitric oxide. We propose that the
modified dinitrosyl iron complex in proteins will have to be
decomposed, followed by the reassembly of new iron-sulfur
clusters into the apoproteins, probably by the products of a
highly conserved gene cluster iscSUA-hscBA-fdx in bacteria
(27–29). To remove the dinitrosyl iron complex from protein,
cellular reducing equivalents will be required. Previous studies
indicated that biological thiols could destabilize the oxidized
[2Fe-2S] clusters of the redox transcription factor SoxR
through the redox ligand exchange reactions (30, 31). The observation prompted us to speculate that biological thiols may
also be involved in removing the dinitrosyl iron complexes from
nitric oxide-modified iron-sulfur proteins. As an initial approach, we examined the effect of various cellular reducing
equivalents on the stability of the ferredoxin dinitrosyl iron
complex in vitro. The results showed that L-cysteine can effectively eliminate the EPR signal at gav ⫽ 2.04 of the ferredoxin
dinitrosyl iron complex and release the ferrous iron. Other
biological thiols are much less effective. The possible mechanisms for the L-cysteine-mediated removal of the dinitrosyl iron
complexes from proteins will be discussed.
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Cloning of E. coli Ferredoxin—The coding region for the E. coli
ferredoxin (32) was amplified from wild-type E. coli genomic DNA by
polymerase chain reaction using polymerase chain reaction ready-to-go
beads (Amersham Pharmacia Co.). Two primers were designed to contain an NcoI restriction site in one primer and a HindIII site in the
other. The sequences of the primers are as follows: fdx-1, 5⬘-AGGTTTACCATGGCAAAGATTGTT-3⬘; fdx-2, 5⬘-CCTCTGTTAAAGCTTACGCGCATG-3⬘. The NcoI/HindIII-digested polymerase chain reaction
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FIG. 1. Modification and repair of the ferredoxin [2Fe-2S] clusters when E. coli cells are exposed to nitric oxide. Ferredoxin proteins
were purified as described under “Experimental Procedures.” A, absorption spectra of the ferredoxin samples. Sample 1, Fdx. Ferredoxin protein
was purified from the E. coli cells not treated with nitric oxide. Sample 2, Fdx-NO. Ferredoxin protein was purified from the E. coli cells treated
with nitric oxide. Sample 3, ferredoxin protein was purified from the E. coli cells incubated at 37 °C with aeration for 30 min after treatment with
nitric oxide. All samples contain about 15 M ferredoxin protein. B, EPR spectra of the ferredoxin samples. Ferredoxin samples shown in A were
directly transferred to the EPR tubes for the measurement as described under “Experimental Procedures.” C, EPR spectra of ferredoxin samples
reduced with dithionite. Ferredoxin samples were reduced with freshly prepared sodium dithionite (at a final concentration of 2 mM) before
transferred to the EPR tubes. EPR spectra shown in B and C are in the same scale. Similar results were obtained from three different experiments.
product was purified and ligated to the expression vector pET28b⫹
(Stratagene Co.) to yield pTFDX, containing a six-histidine tag attached
to the C terminus of the ferredoxin polypeptide. The constructed
plasmid was transformed into E. coli BL-21 (DE3) cells (Stratagene Co.)
for the expression of the ferredoxin protein.
Cells and Nitric Oxide Treatments—An overnight E. coli culture
(BL-21 (DE3) containing the pTFDX plasmid) was diluted 100-fold into
1000 ml of fresh LB (Luria-Bertani) medium. After 3.0 h of incubation
in a 37 °C incubator with aeration (250 rpm), isopropyl-␤-D-thiogalactopyranoside (200 M) was added, and incubation continued for another
1.5 h to induce the expression of the ferredoxin protein. The cells were
then spun down at 4000 rpm for 8 min using an Eppendorf 5810R
desktop centrifuge and resuspended gently into 500 ml of prewarmed
LB medium containing the protein synthesis inhibitor chloramphenicol
(at a final concentration of 0.14 mg/ml). One-third of the culture was
harvested immediately by centrifugation and used as a control. The rest
of the culture was transferred to a sealed flask and incubated in a 37 °C
incubator for 10 min without aeration to achieve anoxic conditions.
Nitric oxide-saturated solution was then injected into the E. coli culture
using a gas-tight Hamilton syringe (the final concentration of nitric
oxide was about 5 M). After the treatment with nitric oxide, the E. coli
culture was split into two equal volumes. One of them was harvested
immediately, and the other was harvested after incubation in a 37 °C
incubator with aeration for 30 min. Nitric oxide-saturated solution was
prepared by bubbling pure nitric oxide gas (MG Industries, Malvern,
PA), which had been first passed through a soda lime column (4 – 8mesh) to remove other nitrogen oxides, through previously degassed
water for 15 min (21).
Protein Purification—The E. coli cells prepared above were resuspended into 30 ml of prechilled buffer A (5 mM imidazole, 500 mM NaCl
and 50 mM Tris, pH 7.9). Cells were disrupted by passing them through
a French press once and then centrifuged at 11,000 rpm for 95 min to
remove cell debris. The supernatants (cell extracts) were applied to a
Superflow nickel-agarose column (2 ml) (Qiagen co.) attached to an
ÄKTA-FPLC (Fast Protein Liquid Chromatography) system (Amersham Pharmacia Biotech). The column was then washed with three
column volumes of buffer A and three column volumes of buffer B (15
mM imidazole, 500 mM NaCl, 50 mM Tris, pH 7.9). The ferredoxin
protein was eluted with buffer C (300 mM imidazole, 500 mM NaCl, 50
mM Tris, pH 7.9). The eluted protein was applied to a Hitrap Desalting
column (5 ml) (Amersham Pharmacia Biotech) equilibrated with buffer
D (500 mM NaCl, 50 mM Tris, pH 7.9) to remove imidazole from the
protein samples. The FPLC system was controlled by UNICORN software (Amersham Pharmacia Biotech) that allows a reproducible protein purification profile. The protein concentration was determined by
the Bradford protein assay kit from Bio-Rad, using bovine serum albumin as a standard. The purity of the purified ferredoxin samples was
greater than 90%, judging from its electrophoresis on a 15% polyacrylamide gel containing SDS followed by staining with Coomassie Brilliant
Blue.

UV-visible Spectroscopy—A Beckman DU640 UV-visible spectrometer equipped with a temperature controller was used for measuring the
absorption spectra of the purified ferredoxin samples. The concentration of the ferredoxin [2Fe-2S] cluster was estimated using an extinction coefficient of 11 mM⫺1 cm⫺1 at 415 nm (32). The spectrometer was
also used for determining the ferrous iron released from the ferredoxin
dinitrosyl iron complex by L-cysteine. After incubation of ferredoxin
samples with or without L-cysteine, each reaction solution (1 ml) was
transferred to a prechilled Centricon concentrator (Micron YM-10; Millipore Corp.) and centrifuged using an Eppendorf 5810R desktop centrifuge. The iron indicator ␣,␣-dipyridyl (50 M) was then added to the
flow-through samples to determine the ferrous iron concentration. The
ferrous iron-␣,␣⬘-dipyridyl complex has an absorption maximum at 520
nm with an extinction coefficient of 5.2 mM⫺1 cm⫺1 (30).
EPR Spectroscopy—X-band EPR spectra were recorded using a
Bruker model ESP-300 EPR spectrometer (Louisiana State University)
equipped with an Oxford Instruments 910 continuous flow cryostat
(courtesy of Prof. Brian Hales, Louisiana State University). Routine
EPR measurement conditions were as follows: microwave frequency,
9.50 GHz; microwave power, 1.0 milliwatt; modulation frequency, 100
kHz; modulation amplitude, 1.2 mT1; sample temperature, 20 K; receiver gain, 105. The relative amplitude of the EPR signal was quantified as described previously (21).
RESULTS

Ferredoxin [2Fe-2S] Clusters Are Transiently Modified when
E. coli Cells Are Exposed to a Single Injection of Nitric Oxide—
The E. coli ferredoxin [2Fe-2S] cluster has been used as an
example in this study, because the gene encoding ferredoxin is
highly conserved in both eukaryotic and prokaryotic organisms
(27, 28, 33, 34). To increase the amount of ferredoxin in E. coli
cells, the protein was partially overproduced using the expression plasmid pTFDX, in which a His tag was fused to the C
terminus of the ferredoxin polypeptide. The His tag facilitated
the quantitative protein purification from E. coli cells but did
not affect the assembly of the [2Fe-2S] clusters into the ferredoxin polypeptide. After ferredoxin was induced in exponentially growing E. coli cells for 1.5 h, chloramphenicol was added
to the culture to stop new protein synthesis. The E. coli culture
was then equally divided into three samples. Sample 1 was
used as a control (not treated with nitric oxide). Sample 2 was

1
The abbreviations used are: mT, milliteslas; Fdx, ferredoxin protein
purified from the E. coli cells not treated with nitric oxide; Fdx-NO,
ferredoxin protein purified from the E. coli cells treated with nitric
oxide.
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treated with nitric oxide. Sample 3 was incubated at 37 °C with
aeration for an additional 30 min after treatment with nitric
oxide. The amount of the ferredoxin protein purified from these
three samples was almost the same, indicating that the ferredoxin protein was not quickly degraded in the E. coli cells.
The ferredoxin protein (Fdx) purified from the E. coli cells
not treated with nitric oxide showed a typical absorption spectrum of oxidized ferredoxin [2Fe-2S] clusters with two peaks at
415 and 459 nm in the visible region (32) (Fig. 1A, trace 1).
However, the absorption spectrum of the ferredoxin protein
(Fdx-NO) purified from the E. coli cells treated with nitric oxide
was changed, notably around the peak at 459 nm (trace 2),
indicating that some ferredoxin [2Fe-2S] clusters were modified when E. coli cells were treated with nitric oxide. This
somewhat distorted spectrum of the ferredoxin protein was
fully restored (trace 3) after the E. coli cells were incubated at
37 °C with aeration for an additional 30 min.
Purified ferredoxin samples were further examined using
EPR spectroscopy. As shown in Fig. 1B, the Fdx sample had no
EPR signal, since the oxidized ferredoxin [2Fe-2S] clusters are
diamagnetic and EPR-silent (trace 1). On the other hand, the
Fdx-NO sample showed a dominant EPR signal at gav ⫽ 2.04
(trace 2), a characteristic of the dinitrosyl iron complex (18 –21).
The EPR spectrum was identical to that of the purified Fdx
sample treated with nitric oxide in vitro under anaerobic conditions (data not shown). The same EPR signal at gav ⫽ 2.04
was also observed in the overproduced native ferredoxin (without the His tag) prepared from the E. coli cells treated with
nitric oxide,2 indicating that the His tag did not contribute to
the EPR signal.
Double integration of the EPR signal at gav ⫽ 2.04 of the
Fdx-NO sample (Fig. 1B, trace 2) showed that the concentration of the dinitrosyl iron complex in the sample (contains ⬃15
M total ferredoxin protein) was only about 2.3 M. While this
number may be an underestimate, since some redox intermediates of the ferredoxin dinitrosyl iron complex are diamagnetic
and EPR-silent (18, 21), it is likely that not all ferredoxin
[2Fe-2S] clusters were converted to the dinitrosyl iron complex
when E. coli cells were exposed to nitric oxide. Significantly,
the EPR signal at gav ⫽ 2.04 was almost completely eliminated
in the ferredoxin sample purified from the E. coli cells incubated at 37 °C with aeration for an additional 30 min after
nitric oxide treatment (Fig. 1B, trace 3).
Purified ferredoxin samples were also reduced with freshly
prepared sodium dithionite to determine the amount of intact
ferredoxin [2Fe-2S] cluster in each sample. When the Fdx
sample was reduced with dithionite, a typical EPR spectrum of
the reduced ferredoxin [2Fe-2S] cluster with gx ⫽ gy ⫽ 1.94 and
gz ⫽ 2.02 appeared (Fig. 1C, trace 1). The Fdx-NO sample
reduced with dithionite had a more complicated EPR spectrum
(Fig. 1B, trace 2). The amplitude of the EPR signal at gav ⫽ 2.04
was substantially decreased with the appearance of a new EPR
signal at gav ⫽ 2.01, reflecting the partial reduction of the
ferredoxin dinitrosyl iron complex by dithionite. The incomplete reduction of the ferredoxin dinitrosyl iron complex by
dithionite is probably due to the very low redox midpoint potential of the iron center in the complex (18, 20, 21). The
reduced Fdx-NO sample also showed an EPR signal at g ⫽ 1.94,
a characteristic of the intact ferredoxin [2Fe-2S] cluster. Judging from the amplitudes of the signal at g ⫽ 1.94 in traces 1 and
2 of Fig. 1C, about 40% of the ferredoxin [2Fe-2S] clusters were
modified when the E. coli cells were treated with nitric oxide.
The removal of dithionite by passing the sample through a
Hitrap desalting column restored the EPR spectrum of the

2

P. A. Rogers and H. Ding, unpublished data.

FIG. 2. Effect of biological thiols on the EPR signal at gav ⴝ 2.04
of the ferredoxin dinitrosyl iron complex. The purified Fdx-NO
sample (10 M) was incubated with no addition (trace b) or with 1 mM
L-cysteine (Cys) (trace c), N-acetyl-L-cysteine (NAC) (trace d), or GSH
(trace e) at 37 °C for 20 min under aerobic conditions. After incubation,
samples were transferred directly to the EPR tubes for the measurement. The EPR spectra were recorded as described under “Experimental Procedures.”

Fdx-NO to at least 90% of the amplitude of the original EPR
signal at gav ⫽ 2.04 (data not shown). Evidently, the ferredoxin
dinitrosyl iron complex was not disrupted by dithionite treatment, as reported in other cases (18, 21). Trace 3 in Fig. 1C
showed that the amplitude of the EPR signal at g ⫽ 1.94 was
completely restored in the ferredoxin sample purified from the
E. coli cells incubated at 37 °C with aeration for an additional
30 min after nitric oxide treatment. These results demonstrate
that the ferredoxin [2Fe-2S] clusters are modified, forming the
ferredoxin dinitrosyl iron complex, when E. coli cells are exposed to nitric oxide and that the modified iron-sulfur clusters
in ferredoxin are efficiently repaired in living E. coli cells.
L-Cysteine Removes the EPR Signal of the Ferredoxin Dinitrosyl Iron Complex—Fig. 1 showed the dynamic metabolism of
the ferredoxin [2Fe-2S] cluster when E. coli cells were exposed
to a single dose of nitric oxide. During the experiments, we also
found that once E. coli cells were disrupted, the ferredoxin
dinitrosyl iron complex in the cell extracts was stable even
after the cell extracts were incubated at 37 °C for 30 min
aerobically (data not shown). This result indicates that cellular
repairing activity for protein dinitrosyl iron complexes is inactivated when E. coli cells are disrupted. One candidate for such
repair activity will be the cellular reducing equivalents that are
potentially oxidized or substantially diluted during the disruption of the E. coli cells.
As an initial approach, the Fdx-NO sample prepared from
the E. coli cells treated with nitric oxide was incubated with
various biological thiols. After incubation at 37 °C for 20 min
under aerobic conditions, samples were transferred to EPR
tubes and frozen immediately. The EPR spectra of the samples
are shown in Fig. 2. Incubation of the Fdx-NO sample alone
had little effect on the EPR signal at gav ⫽ 2.04. When the
Fdx-NO sample was incubated with L-cysteine, the EPR signal
at gav ⫽ 2.04 was completely eliminated (trace c). In contrast,
N-acetyl-L-cysteine (trace d), glutathione (trace e), reduced thioredoxin and L-serine (data not shown) had no observable effect
on the EPR signal at gav ⫽ 2.04 of the Fdx-NO sample.
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FIG. 3. L-Cysteine stimulates iron release from the ferredoxin dinitrosyl iron complex. Both Fdx and Fdx-NO samples (containing about
15 M ferredoxin protein) were prepared as described under “Experimental Procedures.” A, low field EPR spectra of the ferredoxin samples. The
spectra were recorded in the magnetic field from 10 to 300 mT to detect the “junk” iron (g ⫽ 4.3) in the samples. The Fdx and Fdx-NO samples
were incubated with no addition (Fdx, Fdx-NO) or with 1 mM L-cysteine (Fdx ⫹ Cys, Fdx-NO ⫹ Cys) at 37 °C for 20 min under aerobic conditions.
B, quantification of the ferrous iron in ferredoxin samples using ␣,␣⬘-dipyridyl. After Fdx and Fdx-NO sample were incubated with or without
L-cysteine, samples were transferred to prechilled Centricon centrifugal filter units (Micron YM-10) (Millipore Corp.) and centrifuged at 4000 rpm
for 30 min at 4 °C. The ferrous iron indicator ␣,␣⬘-dipyridyl (50 M) was added to the flow-through for the quantification of the ferrous iron. The
concentration of the ferrous iron in the flow-through was measured at 520 nm (a maximum absorption of the Fe2⫹-␣,␣-dipyridyl complex) using
an extinction coefficient of 5.2 mM⫺1 cm⫺1 (30). The results were the averages from three different experiments.

A possible explanation for the disappearance of the EPR
signal at gav ⫽ 2.04 of the Fdx-NO sample after incubation with
L-cysteine is that the ferredoxin dinitrosyl iron complex could
be reduced by L-cysteine to become diamagnetic and EPR-silent
(18, 25). However, repurification of the ferredoxin sample after
incubation with L-cysteine did not restore any EPR signal at gav
⫽ 2.04 (data not shown), indicating that L-cysteine may remove
the dinitrosyl iron complex from ferredoxin proteins.
L-Cysteine Releases Ferrous Iron from Ferredoxin Dinitrosyl
Iron Complexes—If L-cysteine destabilizes the dinitrosyl iron
complex and eventually removes the complex from ferredoxin
protein, we would expect iron to be released from the ferredoxin
dinitrosyl iron complex after incubation with L-cysteine. To
explore this possibility, we first examined the low field EPR
spectra of both Fdx and Fdx-NO samples after incubation with
or without L-cysteine. The EPR signal at g ⫽ 4.3 represents the
“junk” ferric iron in a low symmetry environment with an S of
2⁄5 (35). As shown in Fig. 3A, no EPR signal at g ⫽ 4.3 was seen
in both purified Fdx and Fdx-NO samples. Incubation of the
Fdx sample with L-cysteine produced no EPR signal at g ⫽ 4.3
either. Remarkably, an EPR signal at g ⫽ 4.3 was observed
after the Fdx-NO sample was incubated with L-cysteine, indicating that iron is released from the ferredoxin dinitrosyl iron
complex.
To further quantitatively determine the iron release from the
ferredoxin samples, the protein was separated from the reaction mixture using Centricon Centrifugal Filters after the sample was incubated with or without L-cysteine. The flow-through
of each sample was collected, and the concentration of
the ferrous iron in the flow-through was determined using the
ferrous iron indicator ␣,␣-dipyridyl (30). As expected, very little
ferrous iron was observed in both Fdx and Fdx-NO samples
(Fig. 3B). The addition of dithionite to the flow-through samples to reduce any ferric iron did not increase the amount of the
ferrous iron. When the Fdx sample (containing ⬃15 M ferredoxin protein) was incubated with L-cysteine, only a small
amount of the ferrous iron (⬃ 1.2 M) was detected in the
flow-through. Further incubation of the Fdx sample with Lcysteine (up to 1 h) did not increase the ferrous iron release. In
addition, over 95% of the [2Fe-2S] clusters in the Fdx sample
remained intact after incubation with L-cysteine (data not
shown). These results indicate that released iron in the Fdx
sample did not come from the intact ferredoxin [2Fe-2S] clusters. One possible source would be the iron that loosely associates with small amount of apoferredoxin protein in the sample.

FIG. 4. Kinetics of L-cysteine-mediated ferrous iron release
and the disappearance of the EPR signal at gav ⴝ 2.04 of the
ferredoxin dinitrosyl iron complex. The Fdx-NO sample (containing 15 M ferredoxin protein) purified from the E. coli cells treated with
nitric oxide as described under “Experimental Procedures” was incubated with L-cysteine (1 mM) in a 37 °C water bath under aerobic
conditions. At each time point, an aliquot (400 l) was taken and frozen
immediately for the EPR measurement. The ferrous iron release from
the Fdx-NO sample by L-cysteine was monitored using ␣,␣⬘-dipyridyl.
The maximum amount of the ferrous iron released from the sample
after incubation with L-cysteine was about 11 M. Open circles, the
amount of the ferrous iron released; closed circles, the relative amplitude of the EPR signal at gav ⫽ 2.04 of the ferredoxin dinitrosyl iron
complex.

When the Fdx-NO sample (containing ⬃15 M ferredoxin protein) was incubated with L-cysteine, about 10.5 M ferrous iron
was detected in the flow-through of the sample. Since the intact
ferredoxin [2Fe-2S] clusters in the Fdx-NO sample are not
significantly affected by the L-cysteine incubation, at least 9.0
M iron may be released from the ferredoxin dinitrosyl iron
complex in the Fdx-NO sample. Since up to 40% of the ferredoxin [2Fe-2S] clusters were modified in the Fdx-NO sample
(Fig. 1C), the maximum concentration of the ferredoxin dinitrosyl iron complex in the Fdx-NO sample would be about 6.0
M. Thus, up to 1.5 mol of the iron could have been released per
1.0 mol of the ferredoxin dinitrosyl iron complex by L-cysteine.
More experiments are required to accurately determine the
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FIG. 5. Effect of L-cysteine on the EPR signal of the dinitrosyl iron complex in cell extracts. Exponentially growing E. coli cells (without
any expression plasmids) were treated with or without nitric oxide (at a final concentration of 5 M). The cells were centrifuged and resuspended
in a buffer containing 500 mM NaCl and 50 mM Tris (pH 7.9). Cell extracts were prepared as described under “Experimental Procedures.” The
concentration of the cell extracts was adjusted to about 1.0 mg of total cellular protein/ml. A, effect of biological thiols on the EPR signal at gav ⫽
2.04 of the cell extracts. The cell extracts prepared from the E. coli cells treated with nitric oxide (trace b) were incubated at 37 °C for 20 min with
no addition (trace c) or with 1 mM L-cysteine (Cys) (trace d), N-acetyl-L-cysteine (NAC) (trace e), or GSH (trace f). Trace a, the cell extracts prepared
from the E. coli cells not treated with nitric oxide. B, effect of different concentrations of biological thiols on the dinitrosyl iron complexes in the
cell extracts. The cell extracts prepared from the E. coli cells treated with nitric oxide were incubated with different concentrations of L-cysteine
(Cys), N-acetyl-L-cysteine (NAC), and GSH, respectively. Samples were incubated at 37 °C for 20 min under aerobic conditions. The amplitudes of
the EPR signal at gav ⫽ 2.04 were plotted as a function of the thiol concentrations added in the cell extracts before incubation.

stoichiometry of the iron release from the ferredoxin dinitrosyl
iron complex by L-cysteine.
The kinetics for the iron release and the disappearance of the
EPR signal at gav ⫽ 2.04 were further characterized when the
Fdx-NO sample was incubated with L-cysteine at 37 °C aerobically. As shown in Fig. 4, there was a close correlation between
the amount of the iron released and the amplitude of the EPR
signal at gav ⫽ 2.04 when the ferredoxin dinitrosyl iron complex
was incubated with L-cysteine. Interestingly, half of the amplitude of the EPR signal at gav ⫽ 2.04 was removed at about 2
min, while half of the total iron was released from the Fdx-NO
sample at about 6 min. This point will be discussed below.
Dinitrosyl Iron Complexes in Cell Extracts Can Also Be Removed by L-Cysteine—Since L-cysteine can efficiently remove
the dinitrosyl iron complex from ferredoxin proteins, we postulate that L-cysteine may have a general role in decomposing
cellular protein dinitrosyl iron complexes when E. coli cells are
exposed to nitric oxide. Cell extracts were prepared from exponentially growing E. coli cells (without any expression plasmids) treated with nitric oxide. Prepared cell extracts had a
stable EPR signal at gav ⫽ 2.04 even after being incubated at
37 °C for 20 min under aerobic conditions (Fig. 5A, traces b and
c). The gel filtration profile of the cell extracts showed that over
95% of the stable EPR signal at gav ⫽ 2.04 seen in the cell
extracts was associated with the fractions whose molecular
mass was larger than 10 kDa (data not shown). This indicated
that the majority of the dinitrosyl iron complexes in the cell
extracts were associated with cellular proteins. When such
prepared cell extracts were incubated with L-cysteine at 37 °C
for 20 min under aerobic conditions, the EPR signal at gav ⫽
2.04 was almost completely eliminated (Fig. 5A, trace d). NAcetyl-L-cysteine (trace e) or glutathione (trace f) had much less
effect on the EPR signal at gav ⫽ 2.04 of the cell extracts. The
addition of either NADH or NADPH to the cell extracts had
little effect on the EPR signal (data not shown). Titration
experiments showed that 50 M L-cysteine was sufficient to
remove 50% of the EPR signal in the cell extracts after incubation at 37 °C for 20 min aerobically, while other thiols were
not effective in the concentration range used (Fig. 5B).

DISCUSSION

Iron-sulfur proteins often become inactivated when their
iron-sulfur cluster is modified by nitric oxide, forming the dinitrosyl iron complex (6, 11, 18, 19). Using isolated aconitases
from mammalian cells, interrelation between formation of the
dinitrosyl iron complex and inactivation of the enzyme activity
was quantitatively demonstrated (18). Recently, it has also
been proposed that the redox transcription factor SoxR in E.
coli can be activated by nitric oxide through formation of the
dinitrosyl iron complex from its redox-active [2Fe-2S] cluster
(21). Perhaps iron-sulfur proteins are not only the targets of
nitric oxide cytotoxicity (6, 7) but also the signaling receptors of
nitric oxide (8, 21). However, there was no direct evidence
showing that iron-sulfur proteins are modified, forming protein
dinitrosyl iron complexes when organisms are exposed to nitric
oxide. Here, we presented in vivo data showing that up to 40%
of the E. coli ferredoxin [2Fe-2S] clusters are modified forming
the dinitrosyl iron complexes when E. coli cells are exposed to
a single dose of nitric oxide (Fig. 1). The partial modification of
the ferredoxin [2Fe-2S] clusters could be the result of not
enough nitric oxide being added to the E. coli culture in the
experiments.
Since iron-sulfur proteins are involved in many important
cellular activities (8, 9), prompt repair of the modified ironsulfur proteins will be vital if the cells are to survive. Indeed,
the modified iron-sulfur clusters are efficiently repaired when
E. coli cells are returned to normal growth conditions (Fig. 1).
So far, little is known about the repair mechanism for the nitric
oxide-modified iron-sulfur proteins. It seems that such repair
activity preexists in cells, since the protein synthesis inhibitor
chloramphenicol does not prevent cells from repairing the
ferredoxin dinitrosyl iron complex (Fig. 1). Furthermore, when
E. coli cells are disrupted, the repair activity for the protein
dinitrosyl iron complexes is completely inactivated (Fig. 5).
These observations imply that some cellular reducing equivalents may be essential for removing the dinitrosyl iron complexes from protein. During the past few years, a highly conserved gene cluster iscSUA-hscBA-fdx has been identified as
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important for biogenesis of iron-sulfur proteins (27, 28). The
iscSUA cluster encodes three proteins: IscS, IscU, and IscA.
IscS, a pyridoxal phosphate-containing homodimer, is an enzyme catalyzing L-cysteine desulfurization to provide sulfur for
the assembly of iron-sulfur clusters (29, 36). IscU may provide
a scaffold for IscS-mediated assembly of the clusters that are
subsequently used for maturation of iron-sulfur proteins (37,
38). IscA is suggested to be in involved in delivering iron to the
sites of the iron-sulfur cluster assembly (39). The hscBA cluster
encodes two proteins, Hsc66 and Hsc20, that interact with IscU
protein and probably participate in the maturation of ironsulfur proteins (40). The function of ferredoxin encoded by the
gene fdx is not known, although the gene fdx has an essential
role in overall assembly of iron-sulfur clusters (28). It has also
been postulated that ferredoxin is important for biogenesis or
repair of iron-sulfur clusters in Azotobacter vinelandii (33) and
in Saccharomyces cerevisiae (34). Nevertheless, none of these
proteins seem to have the activity that can directly remove the
damaged iron-sulfur clusters from proteins. We propose that
the modified iron-sulfur clusters such as the dinitrosyl iron
complexes will have to be removed from proteins before a new
iron-sulfur cluster can be reassembled into apoproteins. The
reassembly process may be carried out by the products of the
gene cluster iscSUA-hscBA-fdx (27, 28). In order to remove the
modified iron-sulfur clusters from protein, cellular reducing
equivalents such as biological thiols may be essential. Previous
studies indicated that biological thiols have an important role
in the metabolism of the protein iron-sulfur clusters (30, 31).
We speculate that biological thiols may also be involved in
removing the dinitrosyl iron complexes from proteins. The results presented here showed that L-cysteine, but not N-acetylL-cysteine or glutathione, is effective in removing the EPR
signal at gav ⫽ 2.04 of the dinitrosyl iron complex (Fig. 2) and
releasing the iron from the complex (Fig. 3). The kinetics of the
iron release was closely correlated with that of the disappearance of the EPR signal at gav ⫽ 2.04 when the Fdx-NO sample
was incubated with L-cysteine (Fig. 4).
L-cysteine seems to have a general function in removing the
dinitrosyl iron complexes from proteins, since incubation with
L-cysteine can also eliminate the EPR signal at gav ⫽ 2.04 of the
dinitrosyl iron complexes in the cell extracts prepared from the
E. coli cells treated with nitric oxide (Fig. 5). In aerobically
growing E. coli cells, there is about 0.39 mol of L-cysteine/1012
cells, which is equivalent to an intracellular concentration of
0.2 mM L-cysteine (41). This concentration of L-cysteine may be
sufficient to remove the dinitrosyl iron complexes when the
cells are exposed to a single dose of nitric oxide (at a final
concentration of about 5 M) used in this study (Fig. 5). When
E. coli cells are disrupted, the intracellular L-cysteine may be
oxidized or substantially diluted (up to 50-fold) in the cell
extracts such that the concentration of L-cysteine is too low to
remove the dinitrosyl iron complexes from proteins. The apparently stable proteinaceous dinitrosyl iron complexes in the cell
extracts are effectively decomposed when exogenous L-cysteine
is added (Fig. 5). It can be envisioned that if E. coli cells are
exposed to a higher concentration of nitric oxide or for a prolonged period of exposure with a low concentration of nitric
oxide, the intracellular L-cysteine may be consumed, and new
L-cysteine may need to be synthesized. It is worth noting that
there is a cysE-like gene upstream of the gene cluster iscSUAhscBA-fdx, whose product could increase the intracellular Lcysteine pool (27). The physiological role of L-cysteine in repairing the modified iron-sulfur proteins must be investigated
before we can ascertain whether L-cysteine is the cellular factor
that is responsible for removing the dinitrosyl iron complexes
from proteins in E. coli.
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It is intriguing that substitution of an acetyl at the amino
group of L-cysteine (N-acetyl-L-cysteine) or replacement of the
thiol group with a hydroxyl group (L-serine) completely eliminates the ability of L-cysteine to remove the dinitrosyl iron
complexes from proteins. The slightly different pK values of the
thiol group in L-cysteine, N-acetyl-L-cysteine, and glutathione
(31) cannot fully explain their different abilities in removing
the dinitrosyl iron complexes from proteins, since L-cysteine is
almost equally effective at pH 7.5, 7.9, and 8.5 (data not
shown). We suggest that it is the unique redox property of
L-cysteine that allows L-cysteine to directly interact with
the dinitrosyl iron complex in protein and release the iron from
the complex. There are at least two models that can explain the
data presented in this work. First, L-cysteine may interact with
nitric oxide moieties of the dinitrosyl iron complex in protein
and form nitrosylated L-cysteine. Such interaction will leave
the protein with a “naked” iron center that will eventually be
released from proteins into the solution. The unstable iron
center in protein may also be recycled for reassembly of new
iron-sulfur clusters in cells. This model is apparently supported
by the observation that the EPR signal at gav ⫽ 2.04 completely
disappears at 20 min, while the ferrous iron release continues
during the incubation of the Fdx-NO sample with L-cysteine
(Fig. 4). Alternatively, L-cysteine may extrude the dinitrosyl
iron complex from protein by replacing thiol ligands and form
the L-cysteine dinitrosyl iron complex. Since the L-cysteine
dinitrosyl iron complex is very unstable (the half-life of the
L-cysteine dinitrosyl iron complex is less than 1 min in aqueous
solution (26)), the ferrous iron will be released from the complex. The redox reactions involved in the L-cysteine-mediated
removal of the dinitrosyl iron complex from proteins are currently under investigation.
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